Relypsa, Inc. is a privately-held, development stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal disease. Relypsa's lead product candidate is RLY5016, a non-absorbed potassium binder for the management of hyperkalemia. Relypsa is dedicated – more... to discover additional product candidates through use of its proprietary polymer platform.
Established in 2007, Relypsa was formed as a spin-out of Ilypsa, Inc., which was acquired by Amgen in 2007 for $420M. To date, Relypsa has raised $33 million in Series A financing. Investors include 5AM Ventures, New Leaf Venture Partners, Delphi Ventures, and Mediphase Venture Partners. – less – More from ZoomInfo »
Working at Relypsa
What are the average starting salaries, bonuses, benefits and travel requirements like at Relypsa?
What do you like best about working at Relypsa? Are there any great per...
It's always hard to know what to expect when going in for that interview -- and preparation can make all the difference. What is the interview process like at Relypsa?
Every business has its own style. What is the office environment and culture like at Relypsa?
Are people dressed in business casual, jeans and t-shirts, or full-on suits?...
Do you work at Relypsa? How did you find the job? How did you get that first interview?
Any advice for someone trying to get in?
What do you think - will Relypsa grow fast? Are they expanding their staff? How does Relypsa stack up against the competition?